nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—TUBA1A—optic choroid—ocular cancer	0.114	0.342	CbGeAlD
Mebendazole—TUBA1A—pineal body—ocular cancer	0.0753	0.227	CbGeAlD
Mebendazole—TUBA1A—eye—ocular cancer	0.0229	0.0689	CbGeAlD
Mebendazole—TUBA1A—retina—ocular cancer	0.0227	0.0683	CbGeAlD
Mebendazole—TUBA1A—epithelium—ocular cancer	0.0209	0.063	CbGeAlD
Mebendazole—TUBA1A—G2/M Transition—MYBL2—ocular cancer	0.02	0.0299	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—MYBL2—ocular cancer	0.0197	0.0295	CbGpPWpGaD
Mebendazole—TUBA1A—G2/M Transition—RBBP4—ocular cancer	0.017	0.0254	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—E2F3—ocular cancer	0.0167	0.025	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—RBBP4—ocular cancer	0.0167	0.025	CbGpPWpGaD
Mebendazole—TUBA1A—G2/M Transition—CDC25A—ocular cancer	0.0161	0.0242	CbGpPWpGaD
Mebendazole—TUBA1A—lymphoid tissue—ocular cancer	0.0161	0.0485	CbGeAlD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—CDC25A—ocular cancer	0.0159	0.0238	CbGpPWpGaD
Mebendazole—TUBB4B—eye—ocular cancer	0.0152	0.0459	CbGeAlD
Mebendazole—TUBB4B—retina—ocular cancer	0.0151	0.0455	CbGeAlD
Mebendazole—TUBA1A—p73 transcription factor network—CDK6—ocular cancer	0.0142	0.0212	CbGpPWpGaD
Mebendazole—TUBB4B—G2/M Transition—MYBL2—ocular cancer	0.0121	0.018	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—MYBL2—ocular cancer	0.0119	0.0178	CbGpPWpGaD
Mebendazole—TUBB4B—lymphoid tissue—ocular cancer	0.0107	0.0323	CbGeAlD
Mebendazole—TUBB4B—G2/M Transition—RBBP4—ocular cancer	0.0102	0.0153	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—E2F3—ocular cancer	0.0101	0.0151	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—RBBP4—ocular cancer	0.0101	0.0151	CbGpPWpGaD
Mebendazole—TUBB4B—G2/M Transition—CDC25A—ocular cancer	0.00975	0.0146	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—CDC25A—ocular cancer	0.00961	0.0144	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—CDK2—ocular cancer	0.00866	0.013	CbGpPWpGaD
Mebendazole—CYP1A1—epithelium—ocular cancer	0.0078	0.0235	CbGeAlD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00779	0.0117	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—E2F1—ocular cancer	0.00743	0.0111	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—RB1—ocular cancer	0.00712	0.0107	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2C—ocular cancer	0.00696	0.0104	CbGpPWpGaD
Mebendazole—TUBA1A—G2/M Transition—CDK2—ocular cancer	0.0065	0.00973	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00648	0.0097	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—CDK2—ocular cancer	0.00641	0.0096	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00635	0.0095	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00635	0.0095	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00623	0.00932	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00623	0.00932	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00616	0.00921	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—MDM2—ocular cancer	0.00607	0.00908	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—EIF1AX—ocular cancer	0.0058	0.00869	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—E2F5—ocular cancer	0.00579	0.00867	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00572	0.00856	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—E2F4—ocular cancer	0.00568	0.0085	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MYBL2—ocular cancer	0.00568	0.0085	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—E2F2—ocular cancer	0.00557	0.00833	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—RBL1—ocular cancer	0.00557	0.00833	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.0054	0.00808	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.0054	0.00808	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00513	0.00769	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.00512	0.00766	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—CDKN1A—ocular cancer	0.00511	0.00765	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—RBL2—ocular cancer	0.00511	0.00765	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00502	0.00751	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—EP300—ocular cancer	0.00486	0.00728	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—E2F3—ocular cancer	0.00483	0.00722	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—RBBP4—ocular cancer	0.00483	0.00722	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.0047	0.00704	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—RPL39—ocular cancer	0.00464	0.00695	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDC25A—ocular cancer	0.00459	0.00687	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00455	0.00681	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—E2F1—ocular cancer	0.00449	0.00672	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TFDP1—ocular cancer	0.00449	0.00672	CbGpPWpGaD
Mebendazole—ABCB1—retina—ocular cancer	0.00439	0.0132	CbGeAlD
Mebendazole—TUBA1A—p73 transcription factor network—MYC—ocular cancer	0.00424	0.00634	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2C—ocular cancer	0.00421	0.00629	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCND3—ocular cancer	0.00407	0.00609	CbGpPWpGaD
Mebendazole—ABCB1—epithelium—ocular cancer	0.00405	0.0122	CbGeAlD
Mebendazole—TUBB4B—G2/M Transition—CDK2—ocular cancer	0.00393	0.00588	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00391	0.00586	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—CDK2—ocular cancer	0.00387	0.0058	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00383	0.00574	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00383	0.00574	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00382	0.00571	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00376	0.00563	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00376	0.00563	CbGpPWpGaD
Mebendazole—TUBA1A—G2/M Transition—EP300—ocular cancer	0.00365	0.00547	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—EP300—ocular cancer	0.0036	0.00539	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00356	0.00532	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—EIF1AX—ocular cancer	0.00351	0.00525	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—E2F5—ocular cancer	0.0035	0.00524	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00345	0.00517	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—E2F4—ocular cancer	0.00343	0.00513	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYBL2—ocular cancer	0.00343	0.00513	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00339	0.00507	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—E2F2—ocular cancer	0.00336	0.00503	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RBL1—ocular cancer	0.00336	0.00503	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00326	0.00488	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00326	0.00488	CbGpPWpGaD
Mebendazole—ABCB1—lymphoid tissue—ocular cancer	0.00312	0.00941	CbGeAlD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.0031	0.00464	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RBL2—ocular cancer	0.00309	0.00462	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00307	0.00459	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDK6—ocular cancer	0.00303	0.00454	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00303	0.00454	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00292	0.00436	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00292	0.00436	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—E2F3—ocular cancer	0.00291	0.00436	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RBBP4—ocular cancer	0.00291	0.00436	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—RPL39—ocular cancer	0.0028	0.00419	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDC25A—ocular cancer	0.00277	0.00415	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00275	0.00411	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TFDP1—ocular cancer	0.00271	0.00406	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.00261	0.00391	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCND2—ocular cancer	0.00261	0.0039	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—HDAC1—ocular cancer	0.00261	0.0039	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00252	0.00377	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND3—ocular cancer	0.00246	0.00368	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00241	0.0036	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.0024	0.00359	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00236	0.00353	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2B—ocular cancer	0.00234	0.0035	CbGpPWpGaD
Mebendazole—TUBB4B—G2/M Transition—EP300—ocular cancer	0.00221	0.0033	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—EP300—ocular cancer	0.00218	0.00326	CbGpPWpGaD
Mebendazole—CYP1A1—Tryptophan metabolism—MDM2—ocular cancer	0.00215	0.00322	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—E2F1—ocular cancer	0.00214	0.00321	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDK2—ocular cancer	0.00207	0.0031	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00205	0.00306	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00196	0.00294	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00196	0.00294	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDK4—ocular cancer	0.00196	0.00293	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDK2—ocular cancer	0.00185	0.00277	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDK6—ocular cancer	0.00183	0.00274	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00181	0.00271	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00176	0.00263	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00176	0.00263	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDK4—ocular cancer	0.00175	0.00262	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00172	0.00258	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00172	0.00258	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—RB1—ocular cancer	0.0017	0.00254	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.00158	0.00236	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND2—ocular cancer	0.00157	0.00236	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—HDAC1—ocular cancer	0.00157	0.00236	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—RB1—ocular cancer	0.00152	0.00228	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.0015	0.00225	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.0015	0.00224	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00149	0.00223	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00145	0.00217	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2B—ocular cancer	0.00141	0.00211	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.00132	0.00198	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MDM2—ocular cancer	0.0013	0.00194	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—E2F1—ocular cancer	0.0013	0.00194	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—ocular cancer	0.00126	0.00189	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDK2—ocular cancer	0.00125	0.00187	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.00122	0.00183	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN1B—ocular cancer	0.00118	0.00177	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDK4—ocular cancer	0.00118	0.00177	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00118	0.00176	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—EP300—ocular cancer	0.00116	0.00174	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.00114	0.00171	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCND1—ocular cancer	0.00113	0.00169	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDK2—ocular cancer	0.00112	0.00167	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN1A—ocular cancer	0.00109	0.00163	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00106	0.00158	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDK4—ocular cancer	0.00106	0.00158	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—EP300—ocular cancer	0.00104	0.00156	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00103	0.00154	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RB1—ocular cancer	0.00103	0.00154	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MYC—ocular cancer	0.00101	0.00152	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000991	0.00148	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PSPH—ocular cancer	0.000976	0.00146	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RB1—ocular cancer	0.000918	0.00137	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000909	0.00136	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MYC—ocular cancer	0.000906	0.00136	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—EP300—ocular cancer	0.000858	0.00128	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000839	0.00126	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000799	0.0012	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000784	0.00117	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MDM2—ocular cancer	0.000783	0.00117	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PSPH—ocular cancer	0.000779	0.00117	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000776	0.00116	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000762	0.00114	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—ocular cancer	0.000744	0.00111	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000741	0.00111	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000738	0.0011	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1B—ocular cancer	0.000715	0.00107	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—EP300—ocular cancer	0.000702	0.00105	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND1—ocular cancer	0.000682	0.00102	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1A—ocular cancer	0.000659	0.000987	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—EP300—ocular cancer	0.000628	0.000939	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000623	0.000932	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYC—ocular cancer	0.000612	0.000915	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000578	0.000866	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000549	0.000822	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYC—ocular cancer	0.000547	0.000818	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000502	0.000751	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PSPH—ocular cancer	0.00048	0.000719	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000479	0.000716	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000463	0.000693	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—ocular cancer	0.000449	0.000672	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000441	0.000659	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000384	0.000575	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000383	0.000573	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000315	0.000472	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GNA11—ocular cancer	0.000307	0.000459	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GNAQ—ocular cancer	0.000285	0.000427	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000266	0.000398	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GNA11—ocular cancer	0.000245	0.000367	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00023	0.000345	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GNAQ—ocular cancer	0.000228	0.000341	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GNA11—ocular cancer	0.000151	0.000226	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GNAQ—ocular cancer	0.00014	0.00021	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—EP300—ocular cancer	0.000103	0.000154	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—EP300—ocular cancer	8.19e-05	0.000123	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKT1—ocular cancer	6.2e-05	9.28e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—EP300—ocular cancer	5.05e-05	7.55e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKT1—ocular cancer	4.95e-05	7.41e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKT1—ocular cancer	3.05e-05	4.57e-05	CbGpPWpGaD
